Beyond Barriers Therapeutics, Inc.

Glencoe, IL

UEI
FF4KBK5KEXL9
CAGE
8DCS6
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
422 Adams Ave, Glencoe, IL 60022, USA
Website
beyondbarrierstherapeutics.com
Founded
2015
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Beyond Barriers Therapeutics, Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Intranasal treatment for mild traumatic brain injury (broad agency announcement number SO190192) Contract · HT942523C0036 Defense Health Agency $1,878,956

Quick answers

What is Beyond Barriers Therapeutics, Inc.'s UEI?

Beyond Barriers Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is FF4KBK5KEXL9.

What is Beyond Barriers Therapeutics, Inc.'s CAGE code?

Beyond Barriers Therapeutics, Inc.'s CAGE code is 8DCS6.

What is Beyond Barriers Therapeutics, Inc.'s primary NAICS code?

Beyond Barriers Therapeutics, Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).

Where is Beyond Barriers Therapeutics, Inc. located?

Beyond Barriers Therapeutics, Inc.'s physical address in SAM.gov is 422 Adams Ave, Glencoe, IL 60022, USA.

Is Beyond Barriers Therapeutics, Inc. registered in SAM.gov?

Yes. Beyond Barriers Therapeutics, Inc.'s SAM.gov registration is active through June 19, 2027.

What is Beyond Barriers Therapeutics, Inc.'s most recent federal award?

Beyond Barriers Therapeutics, Inc.'s most recent federal contract award is Intranasal treatment for mild traumatic brain injury (broad agency announcement number SO190192) (HT942523C0036), from Defense Health Agency, on July 25, 2023.

On GovTribe

See Beyond Barriers Therapeutics, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors